Laura Schramm

6PUBLICATIONS
1CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 06, 2023
MAF1 is a predictive biomarker in HER2 positive breast cancer.

Stephanie Cabarcas-Petroski, Gabriella Olshefsky, Laura Schramm

|Oct 28, 2022
BDP1 as a biomarker in serous ovarian cancer.

Stephanie Cabarcas-Petroski, Gabriella Olshefsky, Laura Schramm

|Sep 23, 2022
Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas.

Snežana Hinić, April Rich, Nicole V Anayannis

|Apr 12, 2022
BDP1 Alterations Correlate with Clinical Outcomes in Breast Cancer.

Stephanie Cabarcas-Petroski, Laura Schramm

|Mar 25, 2022
Comment on Li et al. <i>BDP1</i> Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. <i>Diagnostics</i> 2021, <i>11</i>, 2364.

Laura Schramm

|Nov 12, 2020
A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma.

Stephanie Cabarcas-Petroski, Patricio I Meneses, Laura Schramm

Pageof 1

Frequent Collaborators

4 joint publications

Stephanie Cabarcas-Petroski